Quantitative and Qualitative Research for "mHealth Program to Support People Living With HIV Across the HIV Care Continuum"

Status unconfirmed · Not applicable

Conditions studied: HIV Infections

In brief

The goal of this randomized control trial (RCT) is to assess the effectiveness of Amp, a mobile health (mHealth) app designed to improve outcomes along the HIV care continuum for young Black men who have sex with men (YBMSM) living with HIV. HIV care continuum (linkage to care, retention, viral suppression), quality of life and self efficacy outcomes will be compared after a 4-month period between the intervention group (use Amp and standard of care) and the control group (standard of care only).

Key facts

Study ID

NCT06181916

Run by

Sentient Research

People needed

300

Starts

2024-04-29

Expected to finish

2024-12-30

Last updated by the study team

2024-04-24

Who can join

Age: 18 and older, up to 29. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• MSM AND;
• Black or African-American AND;
• 18-29 years old AND;
• Diagnosed with HIV during the study period (From April 1, 2024-August 31 2024) OR;
• Diagnosed with HIV in the year prior to the study period (April 1, 2023-March 31, 2024) OR;
• HIV positive but not linked into care OR;
• Fallen out of care (no HIV care visits within last 6 months) OR;
• Currently in care but NOT virally suppressed (viral load ≥200 copies/mL)
• AND, Online access through a mobile device AND;
• Ability to read and write English.

You may not qualify if…

• Currently participating in another HIV care continuum or mobile health intervention
• Plan to leave the study site within the study period
• Cognitively impaired at recruitment or baseline testing
• Has a self-reported health issue that prohibits them from participating

Where it is running

• Sentient Research — West Covina, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.